Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
Globe Newswire12-06-2023, 13:00
Trident and the Ministry of Posts, Telecommunications, and Digital Technology of the Democratic Republic of the Congo Sign an Agreement for the Implementation of the National Digital Identity System 12-02-2025, 17:30